Acelrx Pharmaceuticals reported $247K in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US USD 247K 80K
Baxter International BAX:US USD 109M 16M
Becton, Dickinson and BDX:US USD 104M 5M
Pfizer PFE:US USD 311M 18M
Smiths SMIN:LN GBP 31M 7M
Teva Pharmaceutical TEVA:IT USD 230M 5M